Background: Trachoma is a blinding disease, initiated in early childhood by repeated conjunctival infection with the obligate intracellular bacterium Chlamydia trachomatis. The population prevalence of the clinical signs of active trachoma; ''follicular conjunctivitis" (TF) and/or ''intense papillary inflammation" (TI), guide programmatic decisions regarding the initiation and cessation of mass drug administration (MDA). However, the persistence of TF following resolution of infection at both the individual and population level raises concerns over the suitability of this clinical sign as a marker for C. trachomatis infection.

Methodology/principle Findings: We systematically reviewed the literature for population-based studies and those including randomly selected individuals, which reported the prevalence of the clinical signs of active trachoma and ocular C. trachomatis infection by nucleic acid amplification test. We performed a meta-analysis to assess the relationship between active trachoma and C. trachomatis infection before and after MDA. TF and C. trachomatis infection were strongly correlated prior to MDA (r = 0.92, 95%CI 0.83 to 0.96, p<0.0001); the relationship was similar when the analysis was limited to children. A moderate correlation was found between TI and prevalence of infection. Following MDA, the relationship between TF and infection prevalence was weaker (r = 0.60, 95%CI 0.25 to 0.81, p = 0.003) and there was no correlation between TI and C. trachomatis infection.

Conclusions/significance: Prior to MDA, TF is a good indicator of the community prevalence of C. trachomatis infection. Following MDA, the prevalence of TF tends to overestimate the underlying infection prevalence. In order to prevent unnecessary additional rounds of MDA and to accurately ascertain when elimination goals have been reached, a cost-effective test for C. trachomatis that can be administered in low-resource settings remains desirable.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082620PMC
http://dx.doi.org/10.1371/journal.pntd.0005080DOI Listing

Publication Analysis

Top Keywords

active trachoma
16
trachomatis infection
16
relationship active
8
trachoma ocular
8
chlamydia trachomatis
8
prevalence clinical
8
clinical signs
8
signs active
8
trachomatis
6
infection
6

Similar Publications

Background: Following interventions to eliminate trachoma in the Afar region of Ethiopia, our goal was to reassess the prevalence of trachomatous trichiasis (TT) and trachomatous inflammation-follicular (TF) at the woreda level, and to identify factors associated with the disease.

Methods: Cross-sectional community-based surveys were conducted in 26 trachoma-endemic woredas, employing a standardized approach. Households were selected as the secondary sampling unit.

View Article and Find Full Text PDF

Introduction: Trachoma is caused by the bacterium (). The WHO recommends the SAFE strategy for trachoma elimination: Surgery for trichiasis, Antibiotics, Facial cleanliness and Environmental improvement. Multiple rounds of SAFE implementation have proven insufficient to eliminate trachoma in Ethiopia, where over 50% of the global trachoma burden remains.

View Article and Find Full Text PDF

Chlamydia trachomatis infections in Kenya - sexually transmitted and ocular infections: a scoping review.

Ther Adv Reprod Health

December 2024

Institute of Public Health Genomics, Genetics and Cell Biology Cluster, GROW Research School for Oncology and Development Biology, Maastricht University, Universiteitssingel 50, Maastricht, Limburg 6229 ER, The Netherlands.

Background: (CT), a Gram-negative intracellular bacterium, is differentiated into three biovars associated with distinct clinical syndromes, ranging from trachoma, the world's cause of preventable blindness, to the most common sexually transmitted infection. This variability underscores CT's significant impact on public health, particularly in low-resource settings. In Kenya, where the demographic is predominantly younger, the burden of CT remains poorly understood and potentially underestimated.

View Article and Find Full Text PDF

() is the causative agent of several human diseases, including the sexually transmitted infection chlamydia and eye infection trachoma. As an obligate intracellular bacterial pathogen, invasion is essential for establishing infection and subsequent pathogenesis. To facilitate invasion, secretes effector proteins through its type III secretion system (T3SS).

View Article and Find Full Text PDF
Article Synopsis
  • Trachoma is still a significant health issue in parts of Cameroon, particularly in the northern regions, where surveys from 2016-2022 revealed ongoing cases of active trachoma and trichiasis, despite previous interventions.
  • A total of 151,800 individuals were examined in these surveys, and findings indicated that two evaluation units exceeded the 5% threshold for active trachoma, while ten units exceeded the 0.2% threshold for trichiasis.
  • Continued intervention efforts, including mass antibiotic distribution and improved surgical access, are needed to address these health challenges, with future assessments required to gauge progress towards eliminating trachoma as a public health concern.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!